G. Gómez

发表

Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan

B. Clotet, E. Negredo, J. Puig, 2012, PloS one.

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

B. Clotet, E. Negredo, J. Puig, 2010, AIDS.

Baseline Factors associated with Haematological Toxicity that Leads to a Dosage Reduction of Pegylated Interferon-α2a and Ribavirin in HIV- and HCV-Coinfected Patients on HCV Antiviral Therapy

B. Clotet, G. Sirera, C. Tural, 2005, Antiviral Therapy.

Long-Term Neuropsychiatric Disorders on Efavirenz-Based Approaches: Quality of Life, Psychologic Issues, and Adherence

B. Clotet, E. Negredo, G. Sirera, 2005, Journal of acquired immune deficiency syndromes.

Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control

À. Olvera, T. Wyss-Coray, J. Martinez-Picado, 2017, Journal of Virology.

Interruptions of Antiretroviral Therapy in HIV Infection : Are they Detrimental to Neurocognitive Functioning ?

B. Clotet, E. Negredo, M. Garolera, 2015 .

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

B. Clotet, E. Negredo, M. Garolera, 2010, Journal of NeuroVirology.

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.

B. Clotet, E. Negredo, M. Garolera, 2008, AIDS research and human retroviruses.

Definition of the viral targets of protective HIV-1-specific T cell responses

Todd M. Allen, D. Heckerman, B. Walker, 2011, Journal of Translational Medicine.

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients

Lidia Ruiz, Roger Paredes, Bonaventura Clotet, 2007, AIDS.

Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy.

B. Clotet, G. Sirera, C. Tural, 2005, Antiviral therapy.

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

B. Clotet, E. Negredo, K. Langohr, 2018, The Journal of antimicrobial chemotherapy.

Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs

R. Paredes, B. Clotet, E. Negredo, 2008, AIDS care.

Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients

R. Paredes, B. Clotet, C. Tural, 2007, AIDS care.

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.

B. Clotet, E. Negredo, M. Garolera, 2008, AIDS research and human retroviruses.